Esperion to Report Third Quarter 2022 Financial Results November 1, 2022
October 17 2022 - 8:02AM
Esperion (NASDAQ: ESPR) today announced it will report third
quarter 2022 financial results before the open of the U.S.
financial markets on Tuesday, November 1st, 2022.
Following the release, company management will host a webcast at
8:00 a.m. ET to discuss the Company’s financial results and
business progress. Please click here to pre-register to
participate in the conference call and obtain your dial in number
and PIN.
Already registered? Access with your PIN here.
A live audio webcast can be accessed on the investors and media
section of the Esperion website. Access to the webcast replay will
be available approximately two hours after completion of the call
and will be archived on the Company's website for approximately 90
days.
Esperion TherapeuticsEsperion works hard to
make our medicines easy to get, easy to take and easy to have. We
discover, develop, and commercialize innovative medicines and
combinations to lower cholesterol, especially for patients whose
needs aren’t being met by the status quo. Our entrepreneurial team
of industry leaders is inclusive, passionate, and resourceful. We
are singularly focused on managing cholesterol so you can improve
your health easily. For more information, please visit
www.esperion.com and follow us on Twitter at
www.twitter.com/EsperionInc.
Contact:Corporate Communicationscorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024